Search results
FDA fast track status granted to iECURE neonatal OTC deficiency treatment
Pharmaceutical Technology· 7 days agoThe therapeutic benefits of ECUR-506 have been recognised previously, with the FDA awarding it rare...
US FDA extends review of Ascendis Pharma's hormone disorder therapy - ET HealthWorld | Pharma
The Economic Times· 6 hours agoU.S.-listed shares of the company were down 6.6 per cent in late afternoon trading. The health...
Nausea, fatigue & itching in skin: Jaundice cases at Vengoor rise to 180 in Kerala - Times of India
The Times of India· 1 day agoKOCHI: The number of jaundice patients in Vengoor panchayat has risen to 180. The local body will convene a meeting on Tuesday to form a help group to raise funds to meet the treatment ...
Two babies with kawasaki disease successfully treated at CMCH | Coimbatore News - Times of India
The Times of India· 3 days agoCoimbatore: Two baby girls diagnosed with kawasaki disease, a condition causing inflammation of...
BMS and Zai Lab’s Augtyro gains NMPA approval to treat NSCLC
Pharmaceutical Technology· 2 days agoAugtyro, an orally administered tyrosine kinase inhibitor (TKI) designed to inhibit specific kinases...
A new biocontrol agent to manage ‘foot rot’ disease in Basmati crop: Why this matters
Indian Express· 6 days agoSeeds are first sown in a nursery bed, where they sprout and grow into seedlings, which are then...
Maranalloor woman's death: Neighbours allege daily abuse by drunkard son
Mathrubhumi· 3 hours agoThiruvananthapuram: In connection with Kattakada woman’s death case, more details have surfaced. The...
The challenge of extra-pulmonary TB
The Hindu· 10 hours agoWhile the most common form of tuberculosis (TB), which is pulmonary TB, infects the lungs, some 20% of TB infections develop in the lymph nodes, brain,...
DoH, M42 launch region's largest hybrid cord blood bank - ET HealthWorld
The Economic Times· 20 hours agoHybrid Cord Blood Bank: The service will be introduced across four leading healthcare entities...
NHS introduces Pfizer’s tafamidis for ATTR-CM treatment
Pharmaceutical Technology· 22 hours agoIn May 2024 the NHS announced plans to offer Pfizer‘s Voxelotor (Oxbryta), a new treatment option...